سوق الكيمياء الطبية لاكتشاف الأدوية في الشرق الأوسط وأفريقيا – اتجاهات الصناعة والتوقعات حتى عام 2029

تحليل السوق والرؤى : الكيمياء الطبية في الشرق الأوسط وأفريقيا لسوق اكتشاف الأدوية

من المتوقع أن يحقق سوق الكيمياء الطبية لاكتشاف الأدوية في الشرق الأوسط وأفريقيا نموًا في السوق في الفترة المتوقعة من 2022 إلى 2029. تحلل شركة Data Bridge Market Research أن السوق ينمو بمعدل نمو سنوي مركب قدره 5.7٪ في الفترة المتوقعة من 2022 إلى 2029 ومن المتوقع أن يصل إلى 94.19 مليون دولار أمريكي بحلول عام 2029. إن الانتشار المتزايد لأمراض مثل الزهايمر والإيدز والأمراض المعدية المقاومة للأدوية الأخرى والتركيز المتزايد على تطوير أدوية جديدة للأمراض المتطورة هي المحركات الرئيسية التي دفعت الطلب على السوق في الفترة المتوقعة.

الكيمياء الطبية هي مجال علمي متعدد التخصصات يشمل فريقًا من العلماء (بما في ذلك الكيميائيون العضويون الاصطناعيون والكيميائيون التحليليون وعلماء الأحياء وعلماء السموم وعلماء الأدوية وعلماء الأحياء الدقيقة وعلماء الصيدلة الحيوية) يعملون معًا لاكتشاف الأدوية وتصميمها وتطويرها وتركيبها. علاوة على ذلك، لا تقتصر مساهمة الكيمياء الطبية على مرحلة الاكتشاف فحسب. فهي تحمل غرضها على طول طيف التطوير السريري بالكامل. تنطوي كل مرحلة من مراحل التطوير السريري على كميات زائدة من الأدوية المصاغة لدراسة الفوائد المحتملة في التجارب البشرية. مع مرور الوقت، خضعت الطرق الكيميائية المعتمدة لاكتشاف الجزيئات أيضًا لتغييرات أدت إلى تطوير تقنيات مثل الكيمياء التركيبية (combichem) والتوليف العضوي بمساعدة الميكروويف (MAOS) والفحص البيولوجي عالي الإنتاجية (HTS).

Medicinal chemistry for drug discovery comprises features such increasing need for safe and effective drugs will impact in launching new product by the manufactures into the market which enhance its demand as well as increase in research and development investment for discovery and development of novel drug molecules leads to the market growth. Currently various research studies are taking place which is expected to provide various other opportunities in the medicinal chemistry for drug discovery market. However, technical risks in drug discovery and lack of trained skilled professionals expected to restraint the market growth in the forecast period.

The medicinal chemistry for drug discovery market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Medicinal Chemistry for Drug Discovery Market Scope and Market Size

Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user.The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of process, the global medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the global medicinal chemistry for drug discovery market as it is the first process from where the drug discovery begins and where the biological targets are selected in an area of unmet medical needs. Before target validation target efficacy, safet, potential genetic variation are investigated under the target selection process.
• On the basis of design, the global medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug deisgn, diversity oriented synthesis, chemogenomics, natural products and others.  In 2022, the fragment based variation segment is expected to dominate the global medicinal chemistry for drug discovery market due to the fact that many potent compounds/ inhibitors of diverese targets have been developed using this method. Moreover, it is a powerful method to develop small-molecule compounds starting from fragments binding weakly to targets. Another advantage of fragment based medicinal chemistry meethods is that it offers saving experimental costs, offers diverse hits and plays important role in target-based drug discovery.
• On the basis of drug type, the global medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market due to the fact that as per the market study most of the drug discovery orgsnizations are highly focused on small molecules discovery and less focused on biologics including proteins, peptides among others.
• On the basis of therapeutic area, the global medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalance of cancer and increasing number of clinical trials and research & development activities for development of novel therapeutics.
• On the basis of end user, the global medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the global medicinal chemistry for drug discovery market as most of the market is occupied by contract research organization it is expected to dominate the market. Moroever, major market players signs collaborative agreement with contract research organizations for ongoing clinical trials in order to attain early drug development and approval.

Medicinal Chemistry for Drug Discovery Market Country Level Analysis

The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.

The countries covered in the medicinal chemistry for drug discovery market report are the Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.

South Africa is expected to dominate the market due to the rising funding by several private-public foundations for research projects across South African universities and research institutions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth in Biologics and Initiatives for Research on Rare and Orphan Drugs are boosting the Market Growth of Medicinal Chemistry for Drug Discovery

Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis

Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.

Some of the major players operating in the medicinal chemistry for drug discovery market are Eurofins Scientific, Covance Inc. (now part of the LabCorp Group), WuXi Apptec, Charles River, Thermo Fisher Scientific, Inc., Evotec SE, Piramal Pharma Solutions, Pfizer, Inc., Certara, USA, Sygnature Discovery Limited, Malvern Panalytical Ltd (Parent Company Spectris PLC), Jubilant Biosys Ltd. (A Jubilant Pharmova Limited Company), Taros Chemicals GmbH & Co. KG, Genscript Biotech Corporation, Nereid Therapeutics Inc., BioBlocks, Inc., Charnwood Molecular LTD, Domainex, Aurigene Pharmaceutical Services Ltd. (a subsidiary of Dr. Reddy’s Laboratories Ltd.), Selvita, Nanosyn, and Drug Discovery Alliances Inc. among others.

Various market players provide with the latest technologies of medicinal chemistry for drug discovery which are also accelerating the medicinal chemistry for drug discovery market.

For instance,

• في نوفمبر 2021، قامت شركة Jubilant Biosys Limited بتوسيع مرافقها لدعم خدمات اكتشاف الأدوية الكيميائية وخدمات ADME في المختبر. علاوة على ذلك، تقدم الشركة خدمات لشركة Turning Point Therapeutics Inc. لبرامج أبحاث الأورام الجزيئية الصغيرة. ومن خلال هذا التوسع، استفادت الشركة من عروضها التي سمحت لها باختراق جذورها في سوق الكيمياء الطبية العالمية لاكتشاف الأدوية.
• في فبراير 2021، استحوذت شركة يوروفينز على شركة Beacon Discovery لخبرتها التي اكتسبتها على مدار سنوات في اكتشاف وتطوير الأدوية ونهجها المبتكر. كما تشتهر شركة Beacon Discovery بخبرتها العميقة في أبحاث مستقبلات البروتين المقترنة (GPCR). ومن خلال هذا الاستحواذ، عززت الشركة حضورها في سوق الكيمياء الطبية العالمية لاكتشاف الأدوية.

يعمل التعاون وإطلاق المنتج وتوسيع الأعمال والجوائز والتقدير والمشاريع المشتركة والاستراتيجيات الأخرى من قبل اللاعب في السوق على تعزيز سوق الشركة في الكيمياء الطبية لاكتشاف الأدوية مما يوفر أيضًا فائدة للمنظمة لتحسين عروضها لتوسع القصبات الهوائية.

SKU-67302